Want to see CAC full AI Analyst Report?
Top Page
Camden National
(NASDAQ:CAC)
Select Model
Select Model
Rating:78Outperform
Price Target:
$58.00
â–²(13.28% Upside)
Action:Reiterated
Date:06/19/26
The score is driven primarily by solid financial health (strong cash flow, improving leverage and returns) and attractive valuation (low P/E with a meaningful dividend). Technicals add support via a clear uptrend, while the earnings call reinforces steady margin improvement and strong credit quality, tempered by competitive and expense headwinds and softer recent revenue momentum.
Positive Factors
Strong free cash flow generation
TTM free cash flow nearly equals net income and grew ~36% versus the prior period, indicating durable internal cash generation. That supports dividends, buybacks and capital rebuilding without reliance on volatile market funding, giving financial flexibility through economic cycles.
Negative Factors
Weakening revenue momentum
TTM revenue declined ~2.6% after prior growth, signaling slowing top-line momentum. If loan originations, fee income or mortgage activity remain muted, sustained revenue weakness could limit earnings upside and compress margins despite strong cash flow in the near term.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong free cash flow generation
TTM free cash flow nearly equals net income and grew ~36% versus the prior period, indicating durable internal cash generation. That supports dividends, buybacks and capital rebuilding without reliance on volatile market funding, giving financial flexibility through economic cycles.
Read all positive factors
Camden National (CAC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$918.97M
Dividend Yield3.66%
Average Volume (3M)75.77K
Price to Earnings (P/E)11.5
Beta (1Y)0.85
Revenue Growth19.34%
EPS Growth49.11%
CountryUS
Employees669
SectorFinancial
Sector Strength70
IndustryBanks - Regional
Share Statistics
EPS (TTM)4.71
Shares Outstanding16,914,680
10 Day Avg. Volume103,617
30 Day Avg. Volume75,767
Financial Highlights & Ratios
PEG Ratio1.86
Price to Book (P/B)1.05
Price to Sales (P/S)1.99
P/FCF Ratio12.55
Enterprise Value/Market Cap1.53
Enterprise Value/Revenue3.93
Enterprise Value/Gross Profit6.02
Enterprise Value/Ebitda16.02
Forecast
1Y Price Target
$53.00Price Target Upside3.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)5.38
Revenue Forecast (FY)$273.03M
Camden National Business Overview & Revenue Model
Company Description
Camden National Corporation operates as the bank holding company for Camden National Bank that provides various commercial and consumer banking products and services for consumer, institutional, municipal, non-profit, and commercial customers in t...
How the Company Makes Money
Camden National primarily makes money through (1) net interest income and (2) noninterest income. Net interest income is earned from the spread between interest income generated on interest-earning assets—mainly loans (such as commercial and indus...
Camden National Earnings Call Summary
Earnings Call Date:Apr 28, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Jul 28, 2026
Earnings Call Sentiment Positive
The call highlighted multiple strengths: strong profitability and capital metrics, excellent asset quality, growing wealth/AUA and operational gains from AI/automation, along with ongoing shareholder returns. Headwinds noted were seasonal softness in fees and loans, sequential NIM pressure from lower accretion, increased competition and an expected normalization of expenses in Q2. Management reiterated disciplined, organic growth and a balanced M&A posture. Overall the positives (earnings growth, capital rebuilding, asset quality and tech-enabled efficiency) materially outweigh the transitory and manageable negatives.Positive Updates
Strong Quarterly Earnings
Net income of $21.9 million and diluted EPS of $1.29; adjusted net income and adjusted diluted EPS increased 39% year-over-year excluding noncore acquisition-related items.
Negative Updates
Linked-Quarter NIM Pressure from Lower Accretion
NIM decreased 5 basis points sequentially, driven by lower fair value mark accretion income (approximately $4.3 million in the quarter; management cites ~$4.5 million as a run-rate estimate).
Read all updates
Q1-2026 Updates
Positive
Negative
Strong Quarterly Earnings
Net income of $21.9 million and diluted EPS of $1.29; adjusted net income and adjusted diluted EPS increased 39% year-over-year excluding noncore acquisition-related items.
Read all positive updates
Company Guidance
Management's guidance included a Q2 core net interest margin expansion of 2–5 basis points (Q1 reported NIM 3.24% and core NIM 2.92%), with gradual NIM improvement expected through 2026 and potential approach to ~3.00% in the back half; fair‑value accretion ran about $4.3M this quarter. They expect Q2 noninterest income to rebound to roughly $13.0M and Q2 noninterest expense to normalize to about $37.5M (Q1 noninterest expense was $35.7M). Loan growth is expected to be low‑to‑mid single‑digit for the year (home equity +$10.6M in Q1), deposits were $5.6B (+1% q/q), AUA $2.4B (+11% y/y), tangible common equity 7.64%, tangible book value per share $30.58 (+3% q/q), and credit remains strong (NPLs 22 bps, past‑due loans 6 bps, ACL 92 bps, NCOs $506k / 4 bps).Camden National Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
74
Positive
Cash Flow
81
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 357.81M | 367.34M | 289.72M | 250.32M | 208.89M | 193.91M |
| Gross Profit | 234.05M | 230.62M | 172.11M | 156.07M | 179.29M | 186.05M |
| EBITDA | 87.86M | 91.54M | 69.33M | 57.80M | 81.16M | 91.00M |
| Net Income | 79.72M | 65.16M | 53.00M | 43.38M | 61.44M | 69.01M |
Balance Sheet | ||||||
| Total Assets | 6.96B | 6.97B | 5.81B | 5.71B | 5.67B | 5.50B |
| Cash, Cash Equivalents and Short-Term Investments | 62.46M | 1.03B | 792.76M | 725.61M | 771.30M | 1.73B |
| Total Debt | 602.73M | 644.29M | 544.95M | 529.94M | 309.51M | 255.94M |
| Total Liabilities | 6.25B | 6.28B | 5.27B | 5.22B | 5.22B | 4.96B |
| Stockholders Equity | 710.01M | 696.56M | 531.23M | 495.06M | 451.28M | 541.29M |
Cash Flow | ||||||
| Free Cash Flow | 77.16M | 58.20M | 55.36M | 64.89M | 103.00M | 140.86M |
| Operating Cash Flow | 82.88M | 63.91M | 60.93M | 67.51M | 105.18M | 142.72M |
| Investing Cash Flow | -72.19M | -56.41M | 30.33M | -7.03M | -487.72M | -649.09M |
| Financing Cash Flow | -96.37M | -124.97M | 23.90M | -36.10M | 237.34M | 581.23M |
Camden National Technical Analysis
Positive
51.20
Price Trends
50.02
Positive
48.81
Positive
44.70
Positive
Market Momentum
1.04
Negative
70.14
Negative
89.46
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CAC, the sentiment is Positive. The current price of 51.2 is below the 20-day moving average (MA) of 51.43, above the 50-day MA of 50.02, and above the 200-day MA of 44.70, indicating a bullish trend. The MACD of 1.04 indicates Negative momentum. The RSI at 70.14 is Negative, neither overbought nor oversold. The STOCH value of 89.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CAC.
Camden National Risk Analysis
Camden National disclosed 38 risk factors in its most recent earnings report. Camden National reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Camden National Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $918.97M | 11.46 | 11.66% | 3.66% | 19.34% | 49.11% | |
75 Outperform | $810.08M | 8.91 | 14.62% | 2.93% | 10.73% | 121.24% | |
75 Outperform | $1.03B | 12.70 | 15.09% | 3.55% | 10.15% | 7.32% | |
74 Outperform | $746.56M | 10.66 | 14.15% | 3.09% | -0.77% | 6.41% | |
68 Neutral | $877.95M | 15.29 | 6.26% | 2.58% | 17.28% | -22.85% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
* Financial Sector Average
CAC
Camden National
53.96
14.91
38.17%
MPB
Mid Penn Bancorp
34.24
6.86
25.05%
ORRF
Orrstown Financial Services
40.73
9.91
32.17%
IBCP
Independent Bank
36.04
4.69
14.97%
MCBS
MetroCity Bankshares
35.69
8.11
29.39%
Camden National Corporate Events
Business Operations and StrategyFinancial Disclosures
Camden National Unveils Investor Presentation Highlighting Strategic Growth
Positive
Jun 18, 2026
The company has prepared a new investor presentation for upcoming meetings, outlining its strategic objectives, financial profile, and competitive positioning in the Maine and New Hampshire community banking markets as of 2025–2026. Camden N...
Executive/Board ChangesShareholder Meetings
Camden National Shareholders Approve Directors, Pay and Auditor
Positive
May 21, 2026
At Camden National Corporation’s 2026 Annual Meeting of Shareholders, held virtually on May 19, 2026, approximately 83% of eligible votes were represented, and investors elected eleven directors to the board for one-year terms. Shareholders ...
Business Operations and StrategyExecutive/Board Changes
Camden National Announces Retirement of Chief Technology Officer
Neutral
May 11, 2026
On May 6, 2026, Camden National Corporation announced that Executive Vice President and Chief Technology Officer William H. Martel plans to retire from his role effective July 31, 2026. The planned departure of the company’s top technology e...
Dividends
Camden National Declares Quarterly Dividend, Signals Ongoing Confidence
Positive
Mar 31, 2026
On March 31, 2026, Camden National Corporation announced that its board of directors declared a quarterly dividend of $0.42 per share, payable on April 30, 2026, to shareholders of record as of April 15, 2026. The payout equates to an annualized d...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.